Literature DB >> 8393244

Nucleotide sequence of VP4 and VP7 genes of a unique human rotavirus strain Mc35 with subgroup I and serotype 10 specificity.

T Urasawa1, K Taniguchi, N Kobayashi, K Mise, A Hasegawa, Y Yamazi, S Urasawa.   

Abstract

The VP7 and VP4 genome segments of human rotavirus strain Mc35 (Urasawa et al., J. Infect. Dis. 166, 227-234, 1992) were investigated. Analysis of its VP7 nucleotide and amino acid sequences confirmed that it belongs to G (or VP7) serotype 10; however, the nucleotide sequence homologies between Mc35 and the four G10 bovine strains examined were lower than those among the four G10 bovine strains. The VP4 nucleotide and amino acid sequences of Mc35 were distinct (66.1-68.8% nucleotide and 64.9-70.0% amino acid homologies) from those of previously reported human and animal rotavirus strains representing different P (or VP4) types except for the strain K8 VP4, which was designated as type 3 of human rotavirus VP4 by Gorziglia et al. (Proc. Natl. Acad. Sci. USA., 87, 7155-7159, 1990). The VP4s of the K8 and Mc35 strains showed a relatively high degree of homology (77.6% nucleotide and 86.0% amino acid sequence homologies) and were presumed to represent subtypes of type 3 human rotavirus VP4 (type 3A (K8 VP4) and type 3B (Mc35 VP4)).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393244     DOI: 10.1006/viro.1993.1428

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Serologic and genomic characterization of a G12 human rotavirus in Thailand.

Authors:  M Wakuda; S Nagashima; N Kobayashi; Y Pongsuwanna; K Taniguchi
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Evidence for bovine origin of VP4 and VP7 genes of human group A rotavirus G6P[14] and G10P[14] strains.

Authors:  Souvik Ghosh; Vici Varghese; Sudipta Samajdar; Manju Sinha; Trailokya N Naik; Nobumichi Kobayashi
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

3.  Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus.

Authors:  N P Mahajan; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Serological and genomic characterization of porcine rotaviruses in Thailand: detection of a G10 porcine rotavirus.

Authors:  Y Pongsuwanna; K Taniguchi; M Chiwakul; T Urasawa; F Wakasugi; C Jayavasu; S Urasawa
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Serotype G6 human rotavirus sharing a conserved genetic constellation with natural reassortants between members of the bovine and AU-1 genogroups.

Authors:  M Iizuka; E Kaga; M Chiba; O Masamune; G Gerna; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Genomic characterization of porcine rotaviruses in Italy.

Authors:  V Martella; A Pratelli; G Greco; M Tempesta; M Ferrari; M N Losio; C Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

7.  Identification of human rotavirus strains with the P[14] genotype by PCR.

Authors:  S Arista; E Vizzi; C Alaimo; D Palermo; A Cascio
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  Rotaviruses belonging to the AU-1 genogroup recovered from Israeli infants with diarrhea.

Authors:  I Shif; M Iizuka; I Silberstein; E Mendelson; O Nakagomi
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Naturally occurring dual infection with human and bovine rotaviruses as suggested by the recovery of G1P8 and G1P5 rotaviruses from a single patient.

Authors:  O Nakagomi; Y Isegawa; R L Ward; D R Knowlton; E Kaga; T Nakagomi; S Ueda
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Characterization of G10P[11] rotaviruses causing acute gastroenteritis in neonates and infants in Vellore, India.

Authors:  Miren Iturriza Gómara; Gagandeep Kang; Ajit Mammen; Atanu Kumar Jana; Mary Abraham; Ulrich Desselberger; David Brown; Jim Gray
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.